BASF Pharma Ingredients and Services

Sep 28, 2012
By Pharmaceutical Technology Editors

20 years of making ibuprofen faster

Faster processes: Ibuprofen DC 85 helps to decrease production time and to reduce costs. Designed specifically for direct compression into tablets, Ibuprofen DC 85 offers a number of benefits compared to conventional formulations. A common challenge when processing ibuprofen is the relatively low melting point: the API gradually starts to melt during processing and can stick to the machinery – meaning production must be stopped to clean the tablet punches. The active ingredient in Ibuprofen DC 85, in contrast, is coated with a layer of nanomaterial, which provides protection during manufacturing. The result is reliable fault-free tableting production with higher output rates. Furthermore, as expensive wet granulation and compaction processing steps are no longer necessary, our customers can lower production costs.

Speed of action: Ibuprofen Sodium & Racemic Ibuprofen Lysinate (RIBL) dissolve faster than conventional ibuprofen. This means they provide more rapid and effective pain relief during the first hour – so patients are back to full speed in no time.

BASF, the world leader in generic APIs, has been deploying the industry’s most eco-efficient ibuprofen manufacturing process for over 20 years.

BASF Pharma Ingredients and Services
[email protected]

lorem ipsum